With the results of a recent trial Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalization of patients with heart failure. It’s also hoping to win over national coverage from CMS.
With the results of a recent trial Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalization of patients with heart failure. It’s also hoping to win over national coverage from CMS.
Copyright © 2024 | WordPress Theme by MH Themes
